Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 78.18% is in line with its 5-year average of 79.00%, around the middle of its 5-year range (71.13%–86.42%).
0.22% below its 12-month average of 78.35%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 83.54%.
GROSS MARGIN
78.18%
GROSS MARGIN AVG TTM
78.35%
GROSS MARGIN AVG 3Y
78.20%
GROSS MARGIN AVG 5Y
79.00%
GROSS MARGIN AVG 10Y
81.69%
GROSS MARGIN AVG 15Y
83.07%
GROSS MARGIN AVG 20Y
85.04%
CURRENT VS TTM AVG
-0.22%
CURRENT VS 3Y AVG
-0.02%
CURRENT VS 5Y AVG
-1.04%
CURRENT VS 10Y AVG
-4.29%
CURRENT VS 15Y AVG
-5.89%
CURRENT VS 20Y AVG
-8.07%
SECTOR MEDIAN · HEALTHCARE
40.38%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
+93.61%
vs the sector median at left
Halozyme Therapeutics, Inc.
Market Cap
$13.01B
Gross Margin
78.18%
TTM Avg
78.35%
3Y Avg
78.20%
5Y Avg
79.00%
Market Cap
$12.79B
Gross Margin
98.30%
TTM Avg
98.34%
3Y Avg
98.50%
5Y Avg
98.50%
Market Cap
$13.30B
Gross Margin
93.35%
TTM Avg
96.31%
3Y Avg
90.48%
5Y Avg
92.91%
Market Cap
$12.52B
Gross Margin
21.85%
TTM Avg
27.90%
3Y Avg
28.49%
5Y Avg
28.39%
Market Cap
$12.52B
Gross Margin
30.08%
TTM Avg
33.76%
3Y Avg
35.72%
5Y Avg
36.84%
Market Cap
$12.51B
Gross Margin
12.38%
TTM Avg
12.93%
3Y Avg
14.91%
5Y Avg
16.18%
Market Cap
$12.35B
Gross Margin
95.71%
TTM Avg
68.63%
3Y Avg
54.72%
5Y Avg
59.42%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | $13.01B | 78.18% | 78.35% | 78.20% | 79.00% |
| Corcept Therapeutics Incorporated (CORT)vs › | $12.79B | 98.30% | 98.34% | 98.50% | 98.50% |
| Tempus AI, Inc. (TEM)vs › | $13.22B | 63.98% | 58.85% | 53.03% | 43.30% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $13.30B | 93.35% | 96.31% | 90.48% | 92.91% |
| ICON Public Limited Company (ICLR)vs › | $12.52B | 21.85% | 27.90% | 28.49% | 28.39% |
| Baxter International Inc. (BAX)vs › | $12.52B | 30.08% | 33.76% | 35.72% | 36.84% |
| Penumbra, Inc. (PEN)vs › | $12.52B | 67.84% | 65.17% | 64.50% | 63.66% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.51B | 12.38% | 12.93% | 14.91% | 16.18% |
| Encompass Health Corporation (EHC)vs › | $12.35B | 95.71% | 68.63% | 54.72% | 59.42% |
| Ascendis Pharma A/S (ASND)vs › | $14.31B | 90.18% | 86.45% | 83.14% | 81.21% |
Gross Margin
78.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 83.54% |
| 2026-03-31 | 71.13% |
| 2025-12-31 | 77.39% |
| 2025-09-30 | 79.39% |
| 2025-06-30 | 80.31% |
| 2025-03-31 | 75.02% |
| 2024-12-31 | 85.89% |
| 2024-09-30 | 82.96% |
| 2024-06-30 | 75.20% |
| 2024-03-31 | 76.47% |
| 2023-12-31 | 77.27% |
| 2023-09-30 | 74.62% |
| 2023-06-30 | 77.35% |
| 2023-03-31 | 78.31% |
| 2022-12-31 | 76.79% |
| 2022-09-30 | 77.36% |
| 2022-06-30 | 77.72% |
| 2022-03-31 | 86.42% |
| 2021-12-31 | 78.84% |
| 2021-09-30 | 83.95% |
| 2021-06-30 | 83.13% |
| 2021-03-31 | 79.53% |
| 2020-12-31 | 78.41% |
| 2020-09-30 | 91.48% |
| 2020-06-30 | 89.61% |
| 2020-03-31 | 77.18% |
| 2019-12-31 | 68.91% |
| 2019-09-30 | 51.69% |
| 2019-06-30 | 95.21% |
| 2019-03-31 | 91.84% |
| 2018-12-31 | 90.67% |
| 2018-09-30 | 97.55% |
| 2018-06-30 | 97.63% |
| 2018-03-31 | 90.11% |
| 2017-12-31 | 96.05% |
| 2017-09-30 | 86.93% |
| 2017-06-30 | 76.92% |
| 2017-03-31 | 74.49% |
| 2016-12-31 | 79.48% |
| 2016-09-30 | 71.32% |
| 2016-06-30 | 75.08% |
| 2016-03-31 | 81.74% |
| 2015-12-31 | 83.86% |
| 2015-09-30 | 70.26% |
| 2015-06-30 | 81.23% |
| 2015-03-31 | 65.21% |
| 2014-12-31 | 79.76% |
| 2014-09-30 | 64.80% |
| 2014-06-30 | 67.78% |
| 2014-03-31 | 53.87% |
| 2013-12-31 | 71.68% |
| 2013-09-30 | 95.74% |
| 2013-06-30 | 91.12% |
| 2013-03-31 | 93.76% |
| 2012-12-31 | 97.00% |
| 2012-09-30 | 95.75% |
| 2012-06-30 | 98.15% |
| 2012-03-31 | 99.05% |
| 2011-12-31 | 97.67% |
| 2011-09-30 | 99.95% |
| 2011-06-30 | 99.23% |
| 2011-03-31 | 99.84% |
| 2010-12-31 | 75.12% |
| 2010-09-30 | 99.79% |
| 2010-06-30 | 97.40% |
| 2010-03-31 | 99.84% |
| 2009-12-31 | 97.52% |
| 2009-09-30 | 96.61% |
| 2009-06-30 | 96.84% |
| 2009-03-31 | 99.85% |
| 2008-12-31 | 95.84% |
| 2008-09-30 | 94.69% |
| 2008-06-30 | 97.41% |
| 2008-03-31 | 97.94% |
| 2007-12-31 | 97.82% |
| 2007-09-30 | 93.69% |
| 2007-06-30 | 89.34% |
| 2007-03-31 | 90.59% |
| 2006-12-31 | 90.29% |
| 2006-09-30 | 1.76% |
| 2006-06-30 | 86.18% |
| 2006-03-31 | 68.67% |
| 2005-12-31 | 62.67% |
| 2005-09-30 | 60.65% |
| 2005-06-30 | 54.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | -503.19% |
| 2003-09-30 | 28.43% |
| 2003-06-30 | 91.51% |
| 2003-03-31 | 71.03% |
| 2002-12-31 | -4.23% |
| 2002-09-30 | 78.36% |
